rs121908144
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PP3_StrongPP5_Very_Strong
The NM_057176.3(BSND):c.35T>C(p.Ile12Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000116 in 1,461,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_057176.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000199 AC: 5AN: 251442Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135902
GnomAD4 exome AF: 0.0000116 AC: 17AN: 1461872Hom.: 0 Cov.: 32 AF XY: 0.0000220 AC XY: 16AN XY: 727242
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Bartter disease type 4A Pathogenic:1Uncertain:1
This variant was previously reported in trans with another pathogenic variant in this gene (PMID: 19646679) and co-segregated with Sensorineural deafness with mild renal dysfunction in multiple affected family members with additional meioses meeting strong evidence levels (PMID: 19646679). In addition, it was observed in multiple affected individuals with a consistent phenotype from unrelated families (PMID: 19646679). Functional assays showed that the variant had strong level of impact on gene/protein function (PMID: 19646679). In silico prediction tools and conservation analysis predicted that this variant was probably damaging to the protein structure/function (REVEL: 0.941>=0.6, 3CNET: 0.815>=0.75). A missense variant is a common mechanism associated with Sensorineural deafness with mild renal dysfunction. It has been reported with an extremely low frequency in the gnomAD v2.1.1 (https://gnomad.broadinstitute.org/) dataset. Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. -
- -
not provided Pathogenic:1
This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 12 of the BSND protein (p.Ile12Thr). This variant is present in population databases (rs121908144, gnomAD 0.02%). This missense change has been observed in individual(s) with non-syndromic hearing loss (PMID: 19646679, 21541222). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 4388). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt BSND protein function. Experimental studies have shown that this missense change affects BSND function (PMID: 19646679). For these reasons, this variant has been classified as Pathogenic. -
Hearing loss, autosomal recessive Pathogenic:1
- -
Sensorineural deafness with mild renal dysfunction Pathogenic:1
- -
Bartter syndrome Pathogenic:1
Variant summary: BSND c.35T>C (p.Ile12Thr) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 2e-05 in 251442 control chromosomes. c.35T>C has been reported in the literature as homozygous genotypes in individuals affected with non-syndromic deafness and as a compound heterozygous genotype with another loss of function variant, c.10G>T (p.E4*), in individuals with features of Bartter Syndrome, Type 4a (example, Riazuddin_2009). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function demonstrating intact chloride channel function and impaired chaperone function of the protein in intracellular trafficking (Riazuddin_2009). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at